Summit Therapeutics
SMMT
SMMT
15 hedge funds and large institutions have $4.75M invested in Summit Therapeutics in 2019 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
1.89% less ownership
Funds ownership: 3.51% → 1.62% (-1.9%)
Holders
15
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$161K | |
| 2 | +$44.7K | |
| 3 | +$35.4K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$18.9K |
| 5 |
VF
Virtu Financial
New York
|
+$17.6K |
Top Sellers
| 1 | -$513K | |
| 2 | -$12.6K | |
| 3 | -$12K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$1.67K |